HuGE Literature Finder
Records
1
-
11
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology international 2022 1 16 (1): 148-158. Chen Wei-Ting, Lin Shi-Ming, Lee Wei-Chen, Wu Ting-Jung, Lin Chen-Chun, Shen Chien-Heng, Chang Ming-Ling, Lin Chih-Lang, Yeh Chau-Ti |
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy. The pharmacogenomics journal 2019 Oct . Lin Chen-Chun, Hsu Chao-Wei, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Lai Ming-Wei, Lin Chih-Lang, Chien Rong-Nan, Lin Kwang-Huei, Yeh Chau-Ti |
Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma. Asia-Pacific journal of clinical oncology 2017 Jul . Lin Wey-Ran, Hsu Chao-Wei, Yeh Christopher Sung-Huan, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Lin Chen-Chun, Chu Yu-De, Yeh Chau-Ti |
GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma. Oncology letters 2017 Jun 13 (6): 4215-4223. Liang Kung-Hao, Yeh Ta-Sen, Wu Ren-Chin, Yeh Chun-Nan, Yeh Chau-Ti |
GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma. Oncotarget 2017 Mar . Tsou Yung-Kuan, Liang Kung-Hao, Lin Wey-Ran, Chang Hsien-Kun, Tseng Chen-Kan, Yeh Chau-Ti |
GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy. Medicine 2016 Apr 95 (17): e3487. Lin Wey-Ran, Chiang Jy-Ming, Liang Kung-Hao, Lim Siew-Na, Lai Ming-Wei, Tsou Yung-Kuan, Hsieh Tzu-Yun, Hsu Chih-Kai, Yeh Chau-Ti |
GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Pharmacogenomics 2016 Feb . Liang Kung-Hao, Lin Chih-Lang, Chen Sung-Fang, Chiu Chih-Wei, Yang Pei-Ching, Chang Ming-Ling, Lin Chen-Chun, Sung Kai-Feng, Yeh Cassandra, Hung Chien-Fu, Chien Rong-Nan, Yeh Chau-Ti |
Genotyping the GALNT14 gene by joint analysis of two linked single nucleotide polymorphisms using liver tissues for clinical and geographical comparisons. Oncology letters 2014 Nov 8 (5): 2215-2220. Liang Kung-Hao, Yang Pei-Ching, Yeh Chau-Ti |
GALNT14 genotype, a-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma. Molecular and clinical oncology 2014 Jul 2 (4): 630-640. Lin Wey-Ran, Hsu Chao-Wei, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Huang Ya-Hui, Yeh Chau-Ti |
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. International journal of cancer. Journal international du cancer 2014 Mar 134 (5): 1214-24. Yeh Chau-Ting, Liang Kung-Hao, Lin Chen-Chun, Chang Ming-Ling, Hsu Cheng-Lung, Hung Chien- |
GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC. Pharmacogenomics 2011 Jul 12 (7): 1061-73. Liang Kung-Hao, Lin Chen-Chun, Yeh Chau-Ti |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: